HAVN Life Sciences Inc.
HAVN Life Sciences Inc. (HAVN)
Communiqués de presse
Le 2 août/August 2022
HAVN Life Sciences Inc. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every thirty (30) pre-consolidated common shares.
As a result, the outstanding shares of the company will be reduced to approximately 5,109,665 common shares.
The name and symbol will not change.